# US 2013/0158626 A1 · Devices, systems and methods for treatment of neuropsychiatric disorders

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0158626 A1
- Document ID: US20130158626A1
- Status: Published application
- Kind: A1
- Application number: 13/769,074
- Filed: 2013-02-15
- Published: 2013-06-20
- Earliest claimed: 2009-10-05
- Assignees: The Regents of the University of California
- Inventors: Christopher DeGIORGIO; Ian A. Cook; Alejandro Covalin; Patrick R. Miller; Lara Schrader
- Web page: https://patentgrep.com/patent/US20130158626A1

## CPC

- A61N 1/0456: {Specially adapted for transcutaneous electrical nerve stimulation [TENS]}
- A61N 1/0476: {Array electrodes (including any electrode arrangement with more than one electrode for at least one of the polarities)}
- A61N 1/0492: {Patch electrodes (A61N1/0412, A61N1/0428 take precedence)}
- A61N 1/0504: {Subcutaneous electrodes}
- A61N 1/0529: {Electrodes for brain stimulation}
- A61N 1/0551: {Spinal or peripheral nerve electrodes}
- A61N 1/36021: {for treatment of pain}
- A61N 1/36025: {for treating a mental or cerebral condition}
- A61N 1/36064: {Epilepsy}
- A61N 1/36067: {Movement disorders, e.g. tremor or Parkinson disease (stimulating motor muscle A61N1/36003)}
- A61N 1/36075: {Headache or migraine}
- A61N 1/36082: {Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease}
- A61N 1/36096: {Mood disorders, e.g. depression, anxiety or panic disorder}
- A61N 1/3616: {Voltage density or current density}
- A61N 1/36171: {Frequency}
- A61N 1/36175: {Pulse width or duty cycle}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

The present disclosure relates to methods, devices and systems used for the treatment of mood, anxiety, post traumatic stress disorder, and cognitive and behavioral disorders (collectively, neuropsychiatric disorders) via stimulation of the superficial elements of the trigeminal nerve (“TNS”). More specifically, cutaneous methods of stimulation of the superficial branches of the trigeminal nerve located extracranially in the face, namely the supraorbital, supratrochlear, infraorbital, auriculotemporal, zygomaticotemporal, zygomaticoorbital, zygomaticofacial, infraorbital, nasal and mentalis nerves (also referred to collectively as the superficial trigeminal nerve) are disclosed herein.

## Claims

### Claim 1

A system for trigeminal nerve stimulation for treatment of a neuropsychiatric disorder, the system comprising:
a pulse generator; and
a cutaneous electrode assembly in electrical communication with the pulse generator, the assembly comprising:
a first electrode comprising at least one contact configured for cutaneous placement directly over or adjacent an ophthalmic nerve on one side of a patient's forehead, and
a second electrode comprising at least one contact configured for cutaneous placement directly over or adjacent a remaining ophthalmic nerve on an opposing side of the patient's forehead.

### Claim 2 (depends on 1)

The system of claim 1, further comprising a wire operably connecting the pulse generator and the cutaneous electrode assembly.

### Claim 3 (depends on 1)

The system of claim 1, further comprising a regulating device configured to regulate a maximum charge balanced output current through the first and second electrodes below approximately 30-50 mA.

### Claim 4 (depends on 1)

The system of claim 1, wherein the neuropsychiatric disorder is selected from the group consisting of: mood disorder, cognitive disorder, behavioral disorder and anxiety disorder.

### Claim 5 (depends on 1)

The system of claim 1, wherein the pulse generator is configured to apply electrical signals at a frequency between approximately 20 and 300 Hertz, at a pulse duration between approximately 50 and 500 microseconds, at an output current density of not greater than approximately 25 mA/cm2 and an output charge density of not greater than approximately 10 microCoulomb/cm2 at the cerebral cortex.

### Claim 6

A system for trigeminal nerve stimulation for treatment of a neuropsychiatric disorder, the system comprising:
a pulse generator; and
a cutaneous electrode assembly in electrical communication with the pulse generator, the assembly comprising:
a first electrode contact configured for cutaneous placement directly over or adjacent a trigeminal nerve branch on a patient, and
a second electrode contact configured for cutaneous placement directly over or adjacent the trigeminal nerve branch on the patient, wherein the trigeminal nerve branch is selected from the group consisting of the mandibular nerve and the maxillary nerve.

### Claim 7 (depends on 6)

The system of claim 6, further comprising a wire operably connecting the pulse generator and the cutaneous electrode assembly.

### Claim 8 (depends on 6)

The system of claim 6, further comprising a regulating device configured to regulate a maximum charge balanced output current through the first and second electrode contacts below approximately 30-50 mA.

### Claim 9 (depends on 6)

The system of claim 6, wherein the neuropsychiatric disorder is selected from the group consisting of: mood disorder, cognitive disorder, behavioral disorder and anxiety disorder.

### Claim 10 (depends on 6)

The system of claim 6, wherein the pulse generator is configured to apply electrical signals at a frequency between approximately 20 and 300 Hertz, at a pulse duration between approximately 50 and 500 microseconds, at an output current density of not greater than approximately 25 mA/cm2 and an output charge density of not greater than approximately 10 microCoulomb/cm2 at the cerebral cortex.

### Claim 11

A method for treating a neuropsychiatric disorder by trigeminal nerve stimulation, comprising:
applying a first electrode contact for a cutaneous electrode assembly directly over or adjacent to an ophthalmic nerve on one side of the patient's forehead;
applying a second electrode contact for the cutaneous electrode assembly directly over or adjacent to a remaining ophthalmic nerve on an opposing side of the patient's forehead; and
driving electrical signals through the first and second electrode contacts at specified operational parameters to treat the neuropsychiatric disorder.

### Claim 12 (depends on 11)

The method of claim 11, wherein the step of driving the electrical signals comprises driving the electrical signals at a frequency between approximately 20 and 300 Hertz, at a current of 0.05 to 5 milliamperes (mA) and at a pulse duration of less than or equal to 500 microseconds.

### Claim 13 (depends on 11)

The method of claim 11, wherein the step of driving the electrical signals results in an output current density of not greater than approximately 25 mA/cm2 and a charge density of not greater than approximately 10 microCoulomb/cm2 at the cerebral cortex of the patient.

### Claim 14 (depends on 14)

The method of claim 14, wherein the neuropsychiatric disorder is selected from the group consisting of: mood disorder, cognitive disorder, behavioral disorder and anxiety disorder.

### Claim 15

A method for treating a neuropsychiatric disorder by trigeminal nerve stimulation, comprising:
applying a cutaneous electrode assembly directly over or adjacent to a trigeminal nerve branch on a patient; and
driving electrical signals through electrode contacts in the cutaneous electrode assembly at specified operational parameters to treat the neuropsychiatric disorder, wherein the trigeminal nerve branch is selected from the group consisting of the mandibular nerve and the maxillary nerve.

### Claim 16 (depends on 15)

The method of claim 15, wherein the step of driving the electrical signals comprises driving the electrical signals at a frequency between approximately 20 and 300 Hertz, at a current of 0.05 to 5 milliamperes (mA) and at a pulse duration of less than or equal to 500 microseconds.

### Claim 17 (depends on 15)

The method of claim 15, wherein the step of driving the electrical signals results in an output current density of not greater than approximately 25 mA/cm2 and a charge density of not greater than approximately 10 microCoulomb/cm2 at the cerebral cortex of the patient.

### Claim 18 (depends on 15)

The method of claim 15, wherein the neuropsychiatric disorder is selected from the group consisting of: mood disorder, cognitive disorder, behavioral disorder and anxiety disorder.
